Lucyd, Inc
$1.07
▼
-3.64%
2026-04-21 07:59:01
www.lucyd.co
NCM: LUCY
Explore Lucyd, Inc stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$6.68 M
Current Price
$1.07
52W High / Low
$4.97 / $0.95
Stock P/E
—
Book Value
$1.65
Dividend Yield
—
ROCE
-93.41%
ROE
-83.6%
Face Value
—
EPS
$-1.9
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
13
Beta
3.06
Debt / Equity
—
Current Ratio
9.03
Quick Ratio
7.36
Forward P/E
-2.4
Price / Sales
2.56
Enterprise Value
$0.29 M
EV / EBITDA
-0.04
EV / Revenue
0.11
Rating
Buy
Target Price
$3
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | BioLife Solutions, Inc. | $22.19 | — | $1.04 B | — | -4.34% | -3.37% | $29.62 / $17.86 | $7.72 |
| 2. | LeMaitre Vascular, Inc. | $115 | 44.97 | $2.6 B | 0.87% | 11.72% | 15.8% | $118.01 / $78.01 | $17.28 |
| 3. | Sharps Technology, Inc. | $1.84 | — | $73.85 M | — | -452.36% | -2.03% | $18.23 / $1.42 | $15.68 |
| 4. | OraSure Technologies, Inc. | $3.19 | — | $221.2 M | — | -18.75% | -18.3% | $3.82 / $2.08 | $4.84 |
| 5. | Pro-Dex, Inc. | $53.3 | 15.38 | $174.44 M | — | 22.96% | 30.87% | $70.26 / $23.47 | $12.97 |
| 6. | Jin Medical International Ltd. | $2.08 | 13.77 | $16.4 M | — | 2.06% | 4.75% | $19.7 / $1.64 | $3.79 |
| 7. | AptarGroup, Inc. | $125.33 | 21.29 | $8.05 B | 1.47% | 12.5% | 15.1% | $164.28 / $103.23 | $41.56 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0.96 M | 0.67 M | 0.58 M | 0.45 M | 0.69 M | — |
| Operating Profit | -2.5 M | -1.92 M | -2.17 M | -1.9 M | -2.17 M | — |
| Net Profit | -1.87 M | -1.84 M | -2.11 M | -1.78 M | -2.13 M | — |
| EPS in Rs | -0.3 | -0.29 | -0.33 | -0.28 | -0.34 | -0.99 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 2.66 M | 1.64 M | 1.15 M | 0.66 M |
| Operating Profit | -8.49 M | -7.92 M | -6.86 M | -5.58 M |
| Net Profit | -7.59 M | -7.77 M | -6.66 M | -5.68 M |
| EPS in Rs | -1.2 | -1.23 | -1.06 | -0.9 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 10.14 M | 9.84 M | 6.22 M | 4.69 M |
| Total Liabilities | 1.07 M | 0.74 M | 0.66 M | 0.67 M |
| Equity | 9.07 M | 9.1 M | 5.56 M | 4.02 M |
| Current Assets | 9.44 M | 9.24 M | 5.62 M | 4.24 M |
| Current Liabilities | 1.05 M | 0.74 M | 0.62 M | 0.6 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -7.28 M | -6.74 M | -5.77 M | -3.22 M |
| Investing CF | 4.48 M | -5.16 M | -0.2 M | -0.22 M |
| Financing CF | 6.68 M | 10.24 M | 6.66 M | 6.96 M |
| Free CF | -7.53 M | -7.01 M | -6.02 M | -3.44 M |
| Capex | -0.25 M | -0.27 M | -0.25 M | -0.22 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 41.99% | 74.67% | — | — |
| Earnings Growth % | -16.55% | -17.28% | — | — |
| Profit Margin % | -474.6% | -578.18% | -861.16% | — |
| Operating Margin % | -484.2% | -594.85% | -845.22% | — |
| Gross Margin % | 13.15% | -10.35% | -8.53% | — |
| EBITDA Margin % | -475.07% | -570.52% | -840.28% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2024-07-18 | 1:0.05 |